))
Talking the Cure: Discussing COVID-19’s impact on FDA’s inspection program and next steps after the pandemic
Manage episode 290829676 series 2916794
Inhoud geleverd door Hogan Lovells. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door Hogan Lovells of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.
In this episode, Phil Katz and Jim Johnson continue their conversation about the impact of COVID-19 on FDA’s drug inspection program and the steps companies should take now and in preparation for when the pandemic is coming to an end. For all updates around COVID-19, visit our COVID-19 hub. You can find additional thought leadership and information regarding Medical Devices and Technology Regulatory on HL Engage. If you are interested in more information all around Life Sciences and Health Care, follow us on LinkedIn and Twitter.
…
continue reading
52 afleveringen
Delen
